Aspirin and NSAID Management in High-Risk Patients

Introduction to Aspirin and NSAID Interactions

The American College of Cardiology and other guideline societies recommend avoiding concurrent use of aspirin and NSAIDs in patients with a history of GI bleeding and impaired renal function, as the combination increases GI bleeding risk 3-6 fold and worsens renal function 1
The combination of aspirin and NSAIDs approximately quadruples the risk of serious GI bleeding compared to aspirin alone, with a particularly high risk in patients with prior GI bleeding history 3

The American Heart Association recommends low-dose aspirin (75-100 mg daily) for all maintenance cardiovascular prophylaxis, as higher doses increase bleeding risk without improving efficacy 7
Low-dose aspirin (75 mg daily) reduces cardiovascular events by 29.7% compared to 21.4% with higher doses (500-1500 mg) 7
Lower aspirin doses (75 mg) reduce GI bleeding risk by 40% compared to 300 mg doses and by 30% compared to 150 mg doses 2, 5, 6

Aspirin plus PPI is superior to clopidogrel alone for preventing recurrent bleeding in patients with prior ulcer bleeding 2, 5, 6
Omeprazole or other PPIs are mandatory co-therapy in patients with GI bleeding history taking aspirin 2, 5, 6
Avoid NSAIDs entirely in patients with impaired renal function, as they further decrease renal function and increase bleeding risk when combined with aspirin 1

Uncontrolled hypertension increases bleeding risk, and blood pressure should be optimized before initiating aspirin 3
Men have twice the GI bleeding risk of women at equivalent aspirin doses 3
Ensure H. pylori eradication if present, as this reduces recurrent bleeding risk comparably to PPI therapy 2, 5, 6